← Back to Search

HIIT for Type 2 Diabetes and Atrial Fibrillation (Glucose-AF Trial)

N/A
Recruiting
Led By Jennifer L Reed, PhD
Research Sponsored by Ottawa Heart Institute Research Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline to follow-up after 4-week intervention
Awards & highlights

Glucose-AF Trial Summary

This trial will investigate the effect of HIIT on blood glucose fluctuations, AF symptoms, quality of life and mental health in patients with AF living with type 2 diabetes.

Who is the study for?
This trial is for people with non-permanent atrial fibrillation and type 2 diabetes who don't smoke, can do a heart-lung exercise test, and have their heart rate under control. It's not for those with uncontrolled diabetes, alcohol or substance abuse issues, severe heart valve problems, thickened heart muscles causing blockage, or on insulin therapy.Check my eligibility
What is being tested?
The study tests if high-intensity interval training (HIIT), along with standard care, affects blood sugar levels and symptoms of atrial fibrillation in patients. HIIT involves short bursts of intense exercise followed by recovery periods. The goal is to see if this improves the quality of life for these patients.See study design
What are the potential side effects?
While specific side effects are not listed for HIIT in this context, general risks may include muscle soreness or injury from intense activity. Patients' existing conditions will be monitored closely due to the vigorous nature of the exercises.

Glucose-AF Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to follow-up after 4-week intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to follow-up after 4-week intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Glucose variability
Secondary outcome measures
Atrial fibrillation symptom severity
Atrial fibrillation-related quality of life
Changes in blood biomarker concentrations
+2 more
Other outcome measures
Link between glucose variability and atrial fibrillation symptom severity

Glucose-AF Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: High-intensity interval trainingExperimental Treatment1 Intervention
Participants will complete 12 supervised high-intensity interval exercise sessions (3 times weekly for 4 weeks).
Group II: Standard careActive Control1 Intervention
Participants will not participate in on-site supervised exercise sessions.

Find a Location

Who is running the clinical trial?

Ottawa Heart Institute Research CorporationLead Sponsor
188 Previous Clinical Trials
92,400 Total Patients Enrolled
Jennifer L Reed, PhDPrincipal InvestigatorOttawa Heart Institute Research Corporation
6 Previous Clinical Trials
613 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still spots available for this clinical trial?

"Indeed, the online clinical trial registry (clinicaltrials.gov) reveals that this study is currently looking for enrollees. The trial was first advertised on November 18th 2021 and was last updated a month later, on December 10th."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
The Effect of High-Intensity Interval Training on Glucose Variability and Atrial Fibrillation Symptoms
2021. "The Effect of High-Intensity Interval Training on Glucose Variability and Atrial Fibrillation Symptoms". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04190212.
~11 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top